Verdence Capital Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Verdence Capital Advisors's ELV Position: Q2 2026 in Review
Verdence Capital Advisors reduced its Elevance Health (ELV) stake by 95% in Q2 2026, selling an estimated $4.86M and leaving 717 shares worth $277K. The position accounts for 0.01% of the portfolio, ranked #566.
Verdence Capital Advisors first reported a position in ELV in Q1 2022 and has held it in 18 quarters since. The position peaked at $9.7M in Q3 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Verdence Capital Advisors held 717 shares of Elevance Health worth $277K as of Q2 2026.
- Verdence Capital Advisors sold 13,116 Elevance Health shares in Q2 2026, an estimated $4.86M.
- Elevance Health made up 0.01% of Verdence Capital Advisors's portfolio in Q2 2026, its #566 holding.
- Verdence Capital Advisors first reported a position in Elevance Health in Q1 2022 and has held it in 18 quarters since.
- Verdence Capital Advisors's Elevance Health position peaked at $9.7M in Q3 2024.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.